March 21, 2024 | Client News
2023 Revenue Rises to $726.7 million from $161.7 million in 2022 Adjusted EBITDA Rises to $0.1 million vs. $2.0 million loss Year over Year Engages Third Party to Explore the Potential Divestment of its Restaurant and Food Prep Assets FORT WORTH, TX / ACCESSWIRE / March 20, 2024 / Sadot Group Inc. (NASDAQ:SDOT) (the “Sadot Group” […]
March 21, 2024 | Client News
–Phase 2 OK-101 efficacy data to be released March 22nd, 2024- -KOL Event to be held on April 9th, 2024 at 12 PM ET- LONDON and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease […]
March 21, 2024 | Client News
Vol State is Fifth Contract Win Since Introducing No Setup-fee Plan DETROIT, MI / ACCESSWIRE / March 21, 2024 / Amesite Inc. (NASDAQ:AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces a five-year (5) partnership with Volunteer State Community College to deliver non degreed AI and […]
March 21, 2024 | Client News
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that MitoCareX Bio […]
March 21, 2024 | Client News
SAN DIEGO, March 21, 2024 /PRNewswire/ — Nuvve Holding Corp. (Nasdaq: NVVE), a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform, today announced that it will conduct a conference call to review the annual financial results at 5 PM ET (2 PM PT) on Thursday, March 28, 2024. The Company will issue a press release detailing […]
March 20, 2024 | Client News
MIAMI, March 19, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that the Company’s Board of Directors has approved a 1-for-10 reverse split of the Company’s Class A common stock, par value $0.001 per share and Class B […]
March 20, 2024 | Client News
LONDON and NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA […]
March 19, 2024 | Client News
Vancouver, Canada –News Direct– Splash Beverage Group Inc Splash Beverage CEO Robert Nistico joined Steve Darling from Proactive to share exciting updates about the company’s expanding distribution network for its beverage brands. Splash Beverage owns a growing portfolio of alcoholic and non-alcoholic beverage brands, including Copa di Vino wines by the glass, SALT Naturally Flavored […]
March 19, 2024 | Client News
McCool Ranch Field HH-1 Well Producing ~47 Barrels of Oil per Day; 58X and 35X Wells to be Restarted Shortly Presidents Field HV-3A Well to be Restarted Shortly at S. Salinas Project Bakersfield, CA, March 19, 2024 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: “TPET”, “Trio” or the “Company”), a California-based oil and gas […]
